Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cause-effect relation between hyperfibrinogenemia and vascular disease.

Bryce Kerlin1, Brian C Cooley, Berend H Isermann

  • 1Blood Research Institute, Blood Center of SE Wisconsin, Milwaukee 53226, USA.

Blood
|November 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estradiol loss, the "estrobolome," and midlife symptoms: what the gut microbiome adds to menopause care.

Menopause (New York, N.Y.)·2026
Same author

Defective cerebrovascular development in mice lacking TFPI is restored by activated protein C.

Blood·2026
Same author

Ascorbate elastomer-coated ePTFE grafts inhibit neointimal hyperplasia and enhance vascular healing.

Bioactive materials·2025
Same author

The Role of Neutrophil-to-Lymphocyte Ratio as a Predictor of Orchiectomy or Testicular Atrophy After Torsion in Children: A Multicentric Study.

Journal of personalized medicine·2025
Same author

Coagulation proteases modulate nucleic acid uptake and cGAS-STING-IFN induction in the tumor microenvironment.

JCI insight·2025
Same author

The pivotal role of von Willebrand factor binding to platelet αIIbβ3 in stabilizing the formation of a platelet plug at sites of injury.

Haematologica·2025

Elevated fibrinogen (a blood clotting protein) directly contributes to cardiovascular disease severity. This study demonstrates hyperfibrinogenemia exacerbates vascular remodeling and organ fibrin deposition, proving it

Area of Science:

  • Cardiovascular Science
  • Hematology
  • Molecular Biology

Background:

  • Elevated plasma fibrinogen is linked to cardiovascular disease (CVD).
  • It remains debated whether high fibrinogen causally increases CVD risk or is merely an associated marker.
  • Understanding fibrinogen's role is crucial for CVD risk assessment and treatment.

Purpose of the Study:

  • To investigate the causal role of elevated plasma fibrinogen in cardiovascular disease pathogenesis.
  • To determine if hyperfibrinogenemia independently modulates vascular remodeling and fibrin deposition.
  • To explore the complex interactions of fibrinogen with other hemostatic factors in disease progression.

Main Methods:

  • Utilized a transgenic mouse model engineered for hyperfibrinogenemia.

Related Experiment Videos

  • Analyzed fibrin deposition in specific organs under elevated fibrinogen conditions.
  • Assessed the impact of hyperfibrinogenemia on stasis-induced vascular remodeling (neointimal hyperplasia).
  • Investigated fibrinogen's effect on thrombin generation in response to procoagulant stimuli.

    • Main Results:

    • Hyperfibrinogenemia led to increased fibrin deposition in organs.
    • Fibrinogen interacted with other hemostatic factors, influencing fibrin turnover.
    • Elevated fibrinogen exacerbated neointimal hyperplasia in a vascular remodeling model.
    • Paradoxically, hyperfibrinogenemia appeared to suppress thrombin generation under certain conditions.

    Conclusions:

    • Hyperfibrinogenemia is not just a marker but a direct contributor to cardiovascular disease.
    • Elevated fibrinogen can independently or interactively modulate the severity and progression of vascular disease.
    • These findings support targeting fibrinogen levels for managing cardiovascular risk.